Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome

This study has suspended participant recruitment.
(Pending Additional Funding)
Sponsor:
Information provided by (Responsible Party):
Michael Cotten, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01445041
First received: September 15, 2011
Last updated: November 12, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)